89 results
Page 3 of 5
8-K
8e4cjfq5mgqzryjmzzuk
21 Dec 20
Equillium Appoints Industry Veteran, Dolca Thomas, M.D. as Executive Vice President of
8:06am
8-K
EX-99.1
liw1vicj
21 Dec 20
Equillium Appoints Industry Veteran, Dolca Thomas, M.D. as Executive Vice President of
8:06am
8-K
EX-99.1
jzc8bdcgg68nsqsab
7 Dec 20
Equillium Presents Translational Data Demonstrating Impact of Itolizumab on Effector T Cell
9:24am
8-K
EX-99.1
zmb6p3h1l aj
4 Dec 20
Regulation FD Disclosure
9:07am
8-K
EX-99.1
wnc0wfe9oxbg
30 Nov 20
Regulation FD Disclosure
8:01am
8-K
EX-99.1
162y7vpv40tc3bj
25 Nov 20
Equillium Provides Itolizumab COVID-19 Program Update
8:01am
8-K
EX-99.1
jzfh6e 5w9j6g
10 Nov 20
Equillium Reports Third Quarter 2020 Financial Results and Business Highlights
4:11pm
8-K
EX-99.1
bd73kmmrvaokxl6s1c0
29 Oct 20
Equillium Receives FDA Clearance of COVID-19 IND for Phase 3 Trial
5:12pm
8-K
EX-99.1
cjv0nj u7
12 Aug 20
Equillium Reports Second Quarter 2020 Financial Results and Recent Highlights
8:40am
8-K
lkxv1 nbvs8
10 Aug 20
Equillium Announces Positive Interim Data with Itolizumab in Acute GVHD Study
5:21pm
8-K
EX-99.1
ayxn0qb nc1r6s
10 Aug 20
Equillium Announces Positive Interim Data with Itolizumab in Acute GVHD Study
5:21pm
424B5
cbwwh5x
14 Jul 20
Prospectus supplement for primary offering
6:05am
8-K
EX-99.1
l1t5jfaarzi4zbg3e eb
13 Jul 20
Equillium shares topline results of patients treated with itolizumab in clinical trial conducted in India by partner Biocon
6:05am
8-K
EX-99.1
yxk5 su1ahnd389lb
13 May 20
Equillium Reports First Quarter 2020 Financial Results
4:10pm
424B3
gconwpygbm sfea
7 Apr 20
Prospectus supplement
4:57pm